sk&f 82958 has been researched along with Parkinson Disease in 5 studies
Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tratnjek, L | 1 |
Glavan, G | 1 |
Višnjar, T | 1 |
Živin, M | 1 |
Gilmore, JH | 1 |
Watts, VJ | 1 |
Lawler, CP | 1 |
Noll, EP | 1 |
Nichols, DE | 1 |
Mailman, RB | 1 |
Akai, T | 1 |
Ozawa, M | 1 |
Yamaguchi, M | 1 |
Mizuta, E | 1 |
Kuno, S | 1 |
Hanson, GR | 1 |
Keefe, KA | 1 |
Hassani, OK | 1 |
Féger, J | 1 |
5 other studies available for sk&f 82958 and Parkinson Disease
Article | Year |
---|---|
Upregulation and axonal transport of synaptotagmin-IV in the direct-pathway medium spiny neurons in hemi-parkinsonian rats induced by dopamine D1 receptor stimulation.
Topics: Animals; Axonal Transport; Benzazepines; Corpus Striatum; Dopamine Agonists; Dopaminergic Neurons; M | 2016 |
"Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implications.
Topics: Adenylyl Cyclases; Autopsy; Benzazepines; Binding, Competitive; Caudate Nucleus; Dopamine; Dopamine | 1995 |
Combination treatment of the partial D2 agonist terguride with the D1 agonist SKF 82958 in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian cynomolgus monkeys.
Topics: Animals; Benzazepines; Dopamine Agonists; Drug Therapy, Combination; Lisuride; Macaca fascicularis; | 1995 |
Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway.
Topics: Animals; Benzazepines; Caudate Nucleus; Dopamine; Dopamine Agonists; Dopamine D2 Receptor Antagonist | 1999 |
Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
Topics: Adrenergic Agents; Animals; Apomorphine; Benzazepines; Dopamine Agonists; Male; Oxidopamine; Parkins | 1999 |